More than one-third of adults in the USA have obesity, which causes, exacerbates or
adversely impacts numerous medical comorbidities, including diabetes mellitus and …

Obesity is a chronic, relapsing disease that necessitates a multidisciplinary approach to
management. Behavioral changes are the foundation to management, but adjunctive …

Abstract Purpose of Review Obesity is a global health crisis with detrimental effects on all
organ systems leading to worsening disease state and rising costs of care. Persons with …

Obesity is among the leading causes of morbidity and mortality worldwide and its
prevalence continues to increase globally. Because obesity is a chronic, complex, and …

The history of anti-obesity pharmacotherapies is marked by disappointments, often
entangled with societal pressure promoting weight loss and the prevailing conviction that …

Public health initiatives focused on obesity prevention and lifestyle intervention programmes
for patients with obesity have struggled to contain the obesity epidemic to date. In recent …

Obesity is an epidemic and a public health threat. Medical weight management remains one
of the options for the treatment of excess weight and recent advances have revolutionized …

Introduction Pharmacotherapy is a useful adjunct when patients with obesity are unable to
achieve adequate benefit from lifestyle interventions. Areas covered This review covers the …

Obesity pharmacotherapy has evolved significantly over the past 60 years. Today, six anti-
obesity medications (AOMs) are approved by the Federal Drug Administration (FDA) for the …

Obesity is a growing health problem in our society and its treatment has been challenging. In
recent decades, several anti-obesity drugs have been withdrawn from the market because of …